CUA Urology WebEx Series

From the comfort and convenience of your work or home, we welcome you to come join these important conversations:

 

Friday June 22, 2018 {5pm EST | 6pm ADT}

Practical Sequencing Options in Metastatic  Kidney Cancer: How to choose the best therapy for your mRCC patient

Guest Speaker: Dr. Sumanta Pal

Chair & moderator: Dr. Anil Kapoor

By the end of this meeting, participants will be able to:

  •  provide practical sequencing options for metastatic kidney cancer
  • discuss neoadjuvant and adjuvant options for the high risk kidney cancer patient, including collaborative involvement of the Urology and Oncology teams
  • discuss the practical application of PDL1 testing in renal oncology practice

This event is an Accredited Group Learning Activity (Section 1) as defined by the MOC Program of the Royal College of Physicians and Surgeons of Canada, and approved by the CUA. Participants are eligible to claim a maximum of 1 hour of credit.

 

 

Wed. June 27, 2018 {8:00 pm EST} 

Guest Speaker: Bobby Shayegan, MD FRCSC

Sign-up here>>

Thurs. June 28, 2018 {8:00 pm MST}

Guest Speaker: Scott North, MD, FRCPC, MHPE

Sign-up here>>

Evolving Role of Chemotherapy in Metastatic Castrate Resistant Prostate Cancer (mCRPC)

 By participating in this educational session, health care providers can expect to:

  • Describe the patient journey and treatment options for patients with advanced prostate cancer, including the evolving role of chemotherapy
  • Discuss the role of the urologist and other health care providers in making treatment decisions for patients with advanced prostate cancer
  • Identify the factors that require consideration when determining treatment options for patients with advanced prostate cancer

 

This event is an Accredited Group Learning Activity (Section 1) as defined by the MOC Program of the Royal College of Physicians and Surgeons of Canada, and approved by the CUA. Participants are eligible to claim a maximum of 1 hour of credit.

 

 


 ARCHIVED VIDEO RECORDINGS

 

New Immuno-oncology Combinations for Untreated Metastatic Kidney Cancer: An Emerging New Standard of Care?

 

Dr. Scott North & Dr. Anil Kapoor

 


Testosterone Suppression in the Treatment of Recurrent or Metastatic Prostate Cancer - A Canadian Consensus Statement
  

Dr. Laurie Klotz

{CUA Live from GU ASCO} Prostate Cancer Update: Dr. Fred Saad & Dr. Kim Chi - February 8, 2018 

New Developments in the management of metastatic prostate cancer: A look back at 2017

Dr. Fred Saad

 

What is the optimal role for bone targeted therapy in the changing landscape of prostate cancer?

Dr. Anil Kapoor

{Live from the CUA} New Developments in the Management of Advanced Prostate Cancer:
Impact on Cancer Care in Canada

Introduction
Dr. Kim Chi
Dr. Alan So and Dr. Fred Saad
Q & A

Present and Future of Prostate Cancer: Conventional and Molecular Imaging

Dr. Frank Bladou and Dr. Frédéric Pouliot

 

CUA Webseries: 2015-2016

 

 

The CUA WebEx Series is supported by an educational grant from: